Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

Regeneron Pharmaceuticals recently announced that it is testing a medicine for the treatment and/or prevention of Covid-19. According to an article by CNN, the testing of its anti-SARS-CoV-2 antibody combination…

Continue Reading Regeneron Pharmaceuticals is Racing to Have an Antibody “Cocktail” Against COVID-19

A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients

Parkinson's News Today recently published an article featuring a study in Italy showing the benefits of deep brain stimulation in patients with late-stage Parkinson’s disease. The history of the subthalamic…

Continue Reading A Study Confirms Significant Benefits from Deep Brain Stimulation for Late-stage Parkinson’s Patients
The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
source: pixabay.com

The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved

According to a story from PR Newswire, the US Food and Drug Administration (FDA) has just approved a treatment for rare adult-onset Still's disease for the first time ever. The…

Continue Reading The First Treatment for Adult-Onset Still’s Disease Just Got FDA Approved
Bevacizumab is Surprisingly Effective for Treating HHT
https://pixabay.com/en/laboratory-analysis-blood-2356180/

Bevacizumab is Surprisingly Effective for Treating HHT

This year, thanks to COVID-19, the European Hematology Association (EHA) took their annual conference online - but that didn't prevent some intriguing new insights and ideas. In a press release,…

Continue Reading Bevacizumab is Surprisingly Effective for Treating HHT

New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)

At this year's EULAR 2020 E-Congress, Dr. Suzanne Verstappen, MD, presented on how lifestyle changes could benefit patients with rheumatic and musculoskeletal diseases (RMDs). Her interest in the impact of…

Continue Reading New Lifestyle Guidelines Will Improve QOL for Patients with Rheumatic and Musculoskeletal Diseases (RMDs)
Tailored EPOCH-R Treatment Benefits Adults with Burkitt Lymphoma, Says Study
stevepb / Pixabay

Tailored EPOCH-R Treatment Benefits Adults with Burkitt Lymphoma, Says Study

High dose-intensive chemotherapy regimens have been shown as effective for children with Burkitt lymphoma. However, the intensity often leads to discomfort, adverse reactions, and poor outcomes in adult patients, particularly…

Continue Reading Tailored EPOCH-R Treatment Benefits Adults with Burkitt Lymphoma, Says Study

Obstructive Sleep Apnea and ROHHAD: Are They Connected?

by Danielle Bradshaw, In the Cloud Copy A common occurrence among children that have rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation or ROHHAD syndrome is that they’re also…

Continue Reading Obstructive Sleep Apnea and ROHHAD: Are They Connected?
A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function
source: pixabay.com

A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function

By Lauren Thayer from In The Cloud Copy Latent autoimmune diabetes in adults or LADA is a slow progressing form of autoimmune diabetes. Similar to type 1 diabetes, also an…

Continue Reading A Prospective Study: Latent Autoimmune Diabetes in Adults and Beta-Cell Function
Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
source: pixabay.com

Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives

Over 2018 and 2019, BioCryst Pharmaceuticals conducted two surveys to better understand the needs and expectations of hereditary angioedema (HAE) patients. Overall, they found that despite progress in HAE therapies,…

Continue Reading Hereditary Angioedema Patients Explain how an Oral Treatment Option Could Change Their Lives
Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
mohamed_hassan / Pixabay

Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma

According to the ASCO Post, researchers have discovered genomic characteristics of smoldering multiple myeloma that can tell one's risk of progression to multiple myeloma. Dr. Mark Bustoros and his team…

Continue Reading Genomic Markers Show the Risk of Progression for Smoldering Multiple Myeloma
New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy
source: pixabay.com

New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy

According to a story from BioPharma Dive, the drug company Sarepta Therapeutics is pushing forward with its plans to develop a gene therapy for limb-girdle muscular dystrophy (LGMD). The company…

Continue Reading New Data Gives Hope for a Limb-Girdle Muscular Dystrophy Gene Therapy